Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
NCT02005120
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Bevacizumab
DRUG:
recombinant human endostatin
Sponsor
Zhejiang University